(Q42409308)

30 October 2017

Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis (English)

1 reference

30 October 2017

8

Toshifumi Hibi

1 reference

30 October 2017

Makoto Naganuma

1

1 reference

30 October 2017

Nobuo Aoyama

2

1 reference

30 October 2017

Yasuo Suzuki

3

1 reference

30 October 2017

Haruo Nishino

4

1 reference

30 October 2017

Kiyonori Kobayashi

5

1 reference

30 October 2017

Fumihito Hirai

6

1 reference

30 October 2017

Kenji Watanabe

7

1 reference

30 October 2017

16 November 2015

1 reference

Journal of Crohn's and Colitis

30 October 2017

1 reference

30 October 2017

10

1 reference

30 October 2017

7

1 reference

30 October 2017

828-836

1 reference

Prognosis of ulcerative colitis differs between patients with complete and partial mucosal healing, which can be predicted from the platelet count

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Mucosal healing as a target of therapy for colonic inflammatory bowel disease and methods to score disease activity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

A randomized clinical trial of mesalazine suppository: the usefulness and problems of central review of evaluations of colonic mucosal findings

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Long-term safety and efficacy of budesonide in the treatment of ulcerative colitis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Definition and evaluation of mucosal healing in clinical practice

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Clinical Study of the Relation between Mucosal Healing and Long-Term Outcomes in Ulcerative Colitis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Changes in extent of ulcerative colitis: a study on the course and prognostic factors

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Budesonide foam induces remission in patients with mild to moderate ulcerative proctitis and ulcerative proctosigmoiditis

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Effect of budesonide enema on remission and relapse rate in distal ulcerative colitis and proctitis

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4955911

MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials

16 August 2018

1 reference

12 December 2020

Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis

1 reference

12 December 2020

Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study group

1 reference

12 December 2020

Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study)

1 reference

12 December 2020

Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study

1 reference

12 December 2020

Identifiers

DOI

10.1093/ECCO-JCC/JJV208

1 reference

30 October 2017

1 reference

30 October 2017

PubMed publication ID

26577683

1 reference